The Claim
In Japanese adults with type 1 diabetes using sensor-augmented insulin pump therapy, a personalized kinetic model that uses continuous glucose monitoring data (cHbA1c) predicts laboratory-measured HbA1c with a mean absolute deviation of 0.11% (1.2 mmol/mol), demonstrating substantially greater accuracy compared to estimated HbA1c (eHbA1c) and glucose management indicator (GMI), both of which exhibit mean absolute deviations more than four times higher.
What the research says
Not yet evaluated
We are still looking at what the research says.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
For Japanese adults with type 1 diabetes on a smart insulin pump, a new personalized blood sugar tracking method is way more accurate at guessing their lab HbA1c than the usual methods.
See the scientific wording
In Japanese adults with type 1 diabetes using sensor-augmented insulin pump therapy, a personalized kinetic model using continuous glucose monitoring data (cHbA1c) predicts laboratory-measured HbA1c with a mean absolute deviation of 0.11% (1.2 mmol/mol), which is substantially more accurate than estimated HbA1c (eHbA1c) and glucose management indicator (GMI), each of which show mean absolute deviations over four times greater.
What the research says
1 studyThe study tested a smart blood sugar prediction tool in Japanese adults with type 1 diabetes and found it was much more accurate than older methods, just like the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.